| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |